The recently proposed Bedside-to-Outside model aims to bridge inpatient efficacy and free-living effectiveness trials in human nutrition research. Its translational ambition is laudable, yet its core premise – that changes in body mass can be used to calculate energy intake with sufficient precision – rests on problematic assumptions. First, the cited correlation between mass change and energy intake is tautological, not independently validating. Second, reliance on the Wishnofsky rule ignores diet-dependent variation in tissue composition, glycogen, and water. Third, recent analytical work has exposed internal logical inconsistencies in the energy balance model (EBM), while the mass balance model (MBM) delivers superior predictive accuracy by tracking macronutrient mass directly. Finally, omission of hormonal data that reportedly track mass intake more closely than energy intake further weakens the evidentiary foundation. True triangulation requires independent anchors; the present formulation risks circularity by relying solely on EBM assumptions. Six concrete modifications are proposed: (1) inclusion of mass-based metrics as co-primary outcomes; (2) pre-specification and competitive testing of both EBM and MBM predictions; (3) routine quantification of uncertainty propagation; (4) mandatory reporting of hormonal and appetite data; (5) use of MBM predictions as independent validation anchors; and (6) transparent reporting standards for all measured variables. Implemented, these changes would convert the Bedside-to-Outside model from a framework that assumes the EBM into a rigorous test of competing paradigms.